Literature DB >> 11933158

Expression of the vascular endothelial growth factor and its receptors and effects of VEGF during in vitro maturation of bovine cumulus-oocyte complexes (COC).

Ralf Einspanier1, Martin Schönfelder, Karin Müller, Miodrag Stojkovic, Michaela Kosmann, Eckhard Wolf, Dieter Schams.   

Abstract

A complete VEGF system consisting of the ligand and two of its receptors has been detected for the first time in the bovine cumulus-oocyte-complex (COC). In the course of a 24 hr in vitro maturation procedure (IVM), expression of the smaller VEGF transcripts and their specific receptors flt and flk changed remarkably in a time-dependent manner as observed by RT-PCR. The transcript concentrations of VEGF declined within 24 hr of culture, whereas both receptor mRNAs were found enriched between 6 and 12 hr of IVM. In the follicular fluid of growing ovarian follicles, immunoreactive VEGF, measured by RIA, increased significantly, reaching highest concentrations immediately before ovulation of the oocyte. The immunohistochemical localization of VEGF in bovine COCs revealed strong signals within the cumulus cell complex clearly extending beyond the oocyte cytoplasm at the beginning of in vitro maturation. After 24 hr, IVM immunoreactive VEGF disappeared remarkably from cumulus cells and the oocyte cytoplasm. An exogenous application of VEGF at the beginning of a 24 hr IVM significantly improved cleavage rates of zygotes and their development into bovine embryos showing obvious synergistic effects in combination with FSH, when compared with untreated control embryos. In addition, the number of blastomeres in deriving blastocysts increased after VEGF supplementation. These results indicate a functional VEGF system controlling important events beside the known angiogenetic effect during in vivo and in vitro maturation of the bovine COC, possibly affecting the early embryonic viability. Copyright 2002 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11933158     DOI: 10.1002/mrd.10068

Source DB:  PubMed          Journal:  Mol Reprod Dev        ISSN: 1040-452X            Impact factor:   2.609


  6 in total

1.  Temporal patterns of gene regulation and upstream regulators contributing to major developmental transitions during Rhesus macaque preimplantation development.

Authors:  Peter Z Schall; Meghan L Ruebel; Uros Midic; Catherine A VandeVoort; Keith E Latham
Journal:  Mol Hum Reprod       Date:  2019-03-01       Impact factor: 4.025

2.  Placental Growth Factor Is Required for Ovulation, Luteinization, and Angiogenesis in Primate Ovulatory Follicles.

Authors:  Hannah R Bender; Heidi A Trau; Diane M Duffy
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

3.  The regulators of VEGF expression in mouse ovaries.

Authors:  So Young Shin; Ho-Jung Lee; Duck-Sung Ko; Hoi-Chang Lee; Won Il Park
Journal:  Yonsei Med J       Date:  2005-10-31       Impact factor: 2.759

4.  Maternal melatonin selectively inhibits cortisol production in the primate fetal adrenal gland.

Authors:  Claudia Torres-Farfan; Hans G Richter; Alfredo M Germain; Guillermo J Valenzuela; Carmen Campino; Pedro Rojas-García; María Luisa Forcelledo; Fernando Torrealba; María Serón-Ferré
Journal:  J Physiol       Date:  2003-12-12       Impact factor: 5.182

5.  Effect of ganglioside GT1b on the in vitro maturation of porcine oocytes and embryonic development.

Authors:  Seon-Ung Hwang; Yubyeol Jeon; Junchul David Yoon; Lian Cai; Eunhye Kim; Hyunju Yoo; Kyu-Jun Kim; Kyu Mi Park; Minghui Jin; Hyunggee Kim; Sang-Hwan Hyun
Journal:  J Reprod Dev       Date:  2015-09-12       Impact factor: 2.214

6.  Follicular Fluid Levels of Adrenomedullin 2, Vascular Endothelial Growth Factor and its Soluble Receptors Are Associated with Ovarian Response During ART Cycles.

Authors:  Ali Ranjbaran; Hamid Reza Nejabati; Tohid Ghasemnejad; Zeinab Latifi; Kobra Hamdi; Hamed Hajipour; Nathalie Raffel; Zahra Bahrami-Asl; Parvin Hakimi; Aynaz Mihanfar; Mohammad Nouri; Amir Fattahi
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-01-17       Impact factor: 2.915

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.